• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Overcoming Treatment Challenges in EoE

Opinion
Video

Mirna Chehade, MD, MPH, discusses the challenges faced by patients with eosinophilic esophagitis (EoE), including the absence of predictive factors for personalized treatment, the social implications of dietary restrictions, and the need for invasive procedures, while emphasizing the importance of regularly scheduled follow-up visits to address medical, nutritional, and psychosocial factors for better outcomes.

This is a video synopsis/summary of an Insights involving Mirna Chehade, MD, MPH.

Chehade addresses challenges in eosinophilic esophagitis (EoE) treatment, noting the lack of highly effective therapies and predictive factors. Pediatric patients face developmental challenges, impacting crucial stages like oral motor and sensory development. Long-term concerns include failure to thrive and fibrostenotic complications, requiring regular screenings and support staff involvement.

Family support involves regular office visits assessing diet efficacy, psychological well-being, and quality of life. Customized letters and assistance with insurance approvals ease dietary implementation. Communication with the office is encouraged for any concerns during dietary therapy.

Success factors in EoE management include scheduled follow-up visits addressing medical, nutritional, and psychosocial aspects. Monitoring involves follow-ups every 3 to 6 months and endoscopy with biopsies after a year. Stable patients have reduced follow-ups and spaced out endoscopies based on circumstances. This comprehensive approach ensures effective EoE management.

Video synopsis is AI-generated and reviewed by AJMC® editorial staff.

Related Videos
Video 2 - "Payer Needs and Strategies for Evaluating and Covering PDTs"
Video 1 - "Differentiating PDTs from Wellness Apps and Evaluating Efficacy"
Video 4 - "Oral SERDs in Development for ER+/HER2- Metastatic Breast Cancer"
Video 3 - "The Role of Oral SERDs in ER+/HER2- Metastatic Breast Cancer"
"Integrating New PAH Therapies into Clinical Practice"
"Clinical Evidence for Emerging PAH Therapies"
Video 13 - "Individualized Therapy for Specific Infections Associated with Bronchiectasis"
Video 11 - "Social Burden and Goals of Therapy for Patients with Bronchiectasis"
Video 15 - "Ensuring Fair Cardiovascular Care for All: Concluding Perspectives on Disparities and Inclusion"
Video 11 - "Social Burden and Goals of Therapy for Patients with Bronchiectasis"
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.